Search for:
Submit
Submit
Webmail
UCD Access
Canvas
Quick Links
Webmail
UCD Access
Canvas
Tools & Resources
Events Calendar
Newsroom
Strauss Health Sciences Library
Department A-Z Directory
Campus Directory
Leadership
Faculty & Staff Resources
Supporter & Alumni Resources
Student Resources
Mental Health Resources
Campus Map
University Policies
Give Now
CU Campuses
CU Anschutz Medical Campus
CU Boulder
CU Colorado Springs
CU Denver
CU System
CU Online
CU Anschutz Medical Campus
School of Dental Medicine
Graduate School
School of Medicine
College of Nursing
Skaggs School of Pharmacy and Pharmaceutical Sciences
Colorado School of Public Health
Gates Institute
About Us
Our Mission
Our Team
Gates Institute Advisory Board
Gates Institute Research and Clinician Members
Resources
Subscribe to Our Newsletter
Member Publications
Membership
Membership Directory
Membership Information and Application
Membership Benefits
Funding Opportunities
Gates Grubstake Fund
Startup Toolbox
Research Focus
Clinical Trials
Cardiology
Ehlers-Danlos Syndrome (EDS)
Epidermolysis Bullosa (EB)
iPSC's (induced pluripotent stem cells)
Oncology
Ophthalmology
Orthopedics
Wound Care
Education
Gates Summer Internship Program
Graduate Program (CSD)
Contact Us
Facilities
Core Facilities
Gates Biomanufacturing Facility
Gates Institute Newsroom
Filter by category
Research
Education
Clinical Impact
Community
Advancement
Press Releases
Regenerative Medicine
,
Cell and Gene Therapy
Gates Institute’s Top Stories of 2024
by Addie Netsanet
| December 20, 2024
Regenerative Medicine
,
Cell and Gene Therapy
Gates Institute’s Top Stories of 2024
by Addie Netsanet
| December 20, 2024
Awareness
,
Genetics
,
Dermatology
,
rare disease
,
Cell and Gene Therapy
,
Gates Summer Internship Program
From Patients to Investigators: Gates Summer Internship Alumni Appear on Podcast to Raise Awareness of Ehlers-Danlos Research
by Addie Netsanet
| December 09, 2024
Research
,
Blood Cancer
,
Leukemia
,
Cancer
,
Cell and Gene Therapy
,
Stem Cell Transplants
,
Medical Oncology
Early-career Investigator Aims to Transform Leukemia Treatment with a Novel Approach to CAR T-cell Therapy
by Addie Netsanet
| December 02, 2024
Research
,
Blood Cancer
,
Leukemia
,
Cancer
,
Clinical Trials
,
Immunotherapy
,
Cell and Gene Therapy
,
Hematology
New CAR T-Cell Trial Launched Through Gates Institute Packages Two CARs in One Treatment
by Toni Lapp
| November 07, 2024
Age-Related Macular Degeneration (AMD)
,
Retina
,
Cell and Gene Therapy
In Advisory Role, Former Gates Center Associate Director Brings Decades of Expertise to Help Ready iPSC Research Program for Clinical Trials
by Addie Netsanet
| October 17, 2024
Research
,
Osteoarthritis
,
Regenerative Medicine
,
Cell and Gene Therapy
Investigators Credit Gates Grubstake Awards with Positioning Osteoarthritis Research for Major Funding
by Toni Lapp
| August 21, 2024
Research
,
Lung Cancer
,
Immunotherapy
,
Major Project to Address ‘Urgent Need’ For Improved Testing of Cancer Therapies
by Mark Harden
| August 21, 2024
Gates Summer Internship Program
GSIP: Summer of 2024 Reflections
by Jill Cowperthwaite
| August 15, 2024
Research
,
Patient Care
,
Cancer
,
Immunotherapy
,
Health Science Radio podcast
Better. Stronger. Faster. Scientists Rebuild Cancer-Killing Cells
by Chris Casey
| August 06, 2024
Cell and Gene Therapy
,
Bioengineering
Gates Biomanufacturing Facility Prepares for Annual Shutdown
by Toni Lapp
| July 26, 2024
Gates Summer Internship Program
,
Mentoring
Gates Summer Internship Program Celebrates its First Decade
by Jill Cowperthwaite
| July 12, 2024
Blood Cancer
,
Clinical Trials
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute
by Guest Contributor
| June 25, 2024
Research
,
Age-Related Macular Degeneration (AMD)
,
Grant
Paving the Way Toward Transplantation: NIH Awards Support Ophthalmology Retinal Research
by Kara Mason
| June 25, 2024
Pediatric Cancer
,
Blood Cancer
,
Leukemia
,
Cancer
,
Oncology
,
Cell and Gene Therapy
,
Medical Oncology
,
Hematology
Getting to Know Maureen O’Brien, MD, MS
by Toni Lapp
| June 20, 2024
Cell and Gene Therapy
,
Biotechnology
,
Bioengineering
Navigating Operational Complexities in Phase I GMP Cell Therapy Manufacturing: A Compliance Perspective
by Nidhi Kotecha
| June 11, 2024
Cell and Gene Therapy
,
Biotechnology
Gates Institute Taps Leading Biotech Experts for New Advisory Board
by Toni Lapp
| June 10, 2024
Education
,
Philanthropy
,
Gates Summer Internship Program
,
Mentoring
Gates Summer Internship Program Marks 10 Years of Mentorships and Discovery
by Carie Behounek
| June 04, 2024
Research
,
Patient Care
,
Regenerative Medicine
,
Health Science Radio podcast
Multi-Campus Effort Aims to Regenerate Arthritic Joints
by Chris Casey
| April 19, 2024
Research
,
Regenerative Medicine
,
Cell and Gene Therapy
,
Organ donation
From Organ Donor to Clinical Research Expert
by Mary Guiden
| April 02, 2024
Research
,
Announcements
Joints That Could Heal Themselves? Researchers Could Get There in Five Years
by CU Boulder Today
| March 26, 2024
Research
,
Cancer
,
Advancement
,
Cell and Gene Therapy
Nephrologist Aims to Explore CAR T Therapy for Solid Tumors
by Toni Lapp
| March 18, 2024
Research
,
Funding
,
Awards
,
Cell and Gene Therapy
Project to Rev Up Cancer-Fighting Cells Wins Anschutz Acceleration Initiative Grant
by Mark Harden
| February 02, 2024
Funding
,
Cell and Gene Therapy
,
Gates Grubstake Fund Awards over $1.4 Million to CU Anschutz Researchers
by Toni Lapp
| January 08, 2024
Cell and Gene Therapy
,
Gates Institute Names Navin Pinto as Medical Lead
by Toni Lapp
| January 08, 2024
Community
,
The Latest News About CAR T-Cell Therapy
by Greg Glasgow
| January 03, 2024
Cell and Gene Therapy
Gates Institute’s Top Stories of 2023
by Toni Lapp
| December 21, 2023
Research
,
Innovation
,
CU Anschutz 360 Podcast
,
Cell and Gene Therapy
CU Anschutz Harnesses Technology and Innovation to Speed Drug Discovery
by Chris Casey
| December 15, 2023
Pediatric Cancer
,
Blood Cancer
,
Regenerative Medicine
,
Cell and Gene Therapy
Gates Biomanufacturing Facility Deploys CAR T-Cell Process Improvement
by Toni Lapp
| December 14, 2023
Research
,
Retina
,
CellSight Contributes Light-Sensitive Retinal Organoids and RPE Cells to New AMD Study
by Kara Mason
| December 06, 2023
Heart
,
Pediatric surgery
,
Cardiology
,
Gates Summer Internship Program
Patch May Successfully Treat Congenital Heart Defects
by David Kelly
| November 27, 2023
Research
,
Bone Cancer
,
Animal
,
Cell and Gene Therapy
Trial Launched to Test CAR T-Cell Therapy in Dogs Diagnosed With Solid Tumors
by Mary Guiden
| November 07, 2023
Research
,
Regenerative Medicine
,
Cell and Gene Therapy
Gene Therapy Protocol Could Offer New Treatment for Skin-blistering Diseases
by Carie Behounek
| October 27, 2023
Regenerative Medicine
,
Cell and Gene Therapy
Technology Transfer: The Key to Moving Scientific Discoveries Forward
by Guest Contributor
| September 26, 2023
Research
,
Blood Cancer
,
Clinical Trials
,
Cell and Gene Therapy
Behind the Scenes of a CAR T-Cell Trial
by Toni Lapp
| September 15, 2023
Research
,
Cancer
,
From Childhood Fascination With Red Blood Cells to Life-Changing Research
by Chris Casey
| September 11, 2023
Gates Summer Internship Program
GSIP: Summer of 2023 Reflections
by Jill Cowperthwaite
| September 01, 2023
Education
,
Gates Summer Internship Program
Gates Summer Internship Program Celebrates the Class of 2023
by Jill Cowperthwaite
| August 16, 2023
Research
,
rare disease
,
Regenerative Medicine
,
Cell and Gene Therapy
,
Gates Summer Internship Program
Student With Rare Genetic Condition Searches for a Cure at Gates Institute
by Carie Behounek
| July 28, 2023
Leukemia
,
Cancer
,
Clinical Research
,
Clinical Trials
,
Cell and Gene Therapy
New CAR T-Cell Trial Enrolling Patients at CU Anschutz
by Toni Lapp
| July 13, 2023
Research
,
Community
,
ColoradoSPH at CU Anschutz
,
Federal Visit Brings Senator, FDA Commissioner to Campus
by Matthew Hastings
| June 26, 2023
Clinical Trials
,
Regenerative Medicine
,
Cell and Gene Therapy
Executive Director Brings Start-up Experience, Biologics Expertise To GBF Leadership Role
by Toni Lapp
| June 12, 2023
Research
,
Cancer
,
CU Anschutz 360 Podcast
,
Podcast: CU Anschutz Powers Up for Regenerative Medicine Frontier
by Chris Casey
| May 09, 2023
Research
,
Community
,
Regenerative Medicine
,
CU Anschutz Takes the Reins in CAR T Cancer Therapy Research
by Debra Melani
| May 08, 2023
Research
,
Faculty
,
Clinical Trials
,
Giving
,
Dermatology
,
rare disease
,
Regenerative Medicine
,
Cell and Gene Therapy
Cracking the Code for Once 'Incurable' Diseases
by Carie Behounek
| April 21, 2023
Research
,
Faculty
,
Regenerative Medicine
,
Gates Grubstake Fund Awards Over $1.5 Million to Campus Researchers
by Toni Lapp
| March 10, 2023
Faculty
,
Valeria Canto-Soler, PhD: Envisioning a Cure for Blindness
by Kristen O'Neill
| March 10, 2023
Research
,
Regenerative Medicine
,
Gates Institute Pushing CU Anschutz to the Forefront in Cell Therapy
by Toni Lapp
| March 03, 2023
Research
,
Patient Care
,
rare disease
,
Patient With Rare Disease Finds Home at CU Anschutz
by Guest Contributor
| February 24, 2023
Research
,
Blood Cancer
,
Eric Kohler, MD, PhD, Receives Award to Improve CAR T-Cell Therapy
by Greg Glasgow
| February 24, 2023
Research
,
Press Releases
,
CU Researchers Awarded $1.3 Million National Science Foundation Grant
by Mark Couch
| September 16, 2022
Research
,
Age-Related Macular Degeneration (AMD)
,
Retina
,
CellSight Surpasses Benchmarks Toward Making Retinal Transplants a Reality
by Rachel Wittel
| September 12, 2022
Research
,
Retina
,
Awards
,
CellSight Teams Clinch Top Two of Three Awards in National Eye Institute Competition
by Toni Lapp
| September 01, 2022
Research
,
Innovation
,
Patient Care
,
The Building of an Enterprise: Regenerative Medicine Poised for World Stage
by Chris Casey
| July 14, 2022
Research
,
Press Releases
,
Advancement
,
Historic $200 Million Commitment to the University of Colorado Anschutz Medical Campus Fuels Advancements in Treatments and Cures
by Julia Milzer
| May 11, 2022
Research
,
Community
,
Philanthropy
,
Pioneer in Cellular and Gene Therapy Saddles Up For New Frontier at CU Anschutz
by Debra Melani
| May 11, 2022
Gates Summer Internship Program
The Stepping Stones of Scientific Communication
by Madison Rogers
| January 01, 2022
Research
,
Patient Care
,
Magazine
,
Driving Revolutionary Advances in Cancer Treatment
by Greg Glasgow
| November 11, 2021
Research
,
Patient Care
,
Cancer
,
Patient Cancer Free After Cell Therapy Created by CU Anschutz
by David Kelly
| February 08, 2021
Research
,
Innovation
,
Patient Care
,
Hope Realized
by Guest Contributor
| June 02, 2020
Research
,
Patient Care
,
Press Releases
,
Skin Disease Researchers Win Renewed Grants
by Guest Contributor
| November 25, 2019
Campus Life
,
Grubstake Awards highlight remarkable return on investment
by Guest Contributor
| June 26, 2019
Research
,
Dermatology
,
rare disease
,
Regenerative Medicine
CU Anschutz Scientists Awarded $3.8 Million DoD Grant to Manufacture Stem Cell Therapies
by Guest Contributor
| April 12, 2018
Canto-Soler brings visionary aspirations to Gates Center for Regenerative Medicine
by Kathleen Bohland
| August 30, 2017
MS, macular degeneration and nanoparticle researchers win Gates grants
by Michael Davidson
| April 18, 2017
Research
,
Regenerative Medicine
Seven-year study pays off with ‘most detailed’ picture of head and neck cancer stem cells to date
by Guest Contributor
| September 19, 2016
Research
,
Regenerative Medicine
CU Scientists’ Discovery Could Lead to New Cancer Treatment
by Guest Contributor
| September 02, 2014
Load more
Gates Institute In the News
The Denver Post
CU studying use of patients’ own reprogrammed cells to attack cancer as alternative to more chemo
March 14, 2024
UC Davis News
UC Davis Graduating Student Poised to Help Those With Rare Condition
December 12, 2023
Colorado Bioscience Association
Building a Life Sciences Pipeline: Cell and Gene Therapy Momentum
March 06, 2023
Genetic Engineering & Biotechnology News
University Creates Innovative Model for Running a GMP Manufacturing Facility
February 08, 2023
PR Newswire
Gates Biomanufacturing Facility Announces Manufacture of Recombinant Protein - Alzheimer's Disease Vaccine for Institute for Molecular Medicine's Clinical Trials
November 04, 2022
Nature
Colorado institute pits world-class CAR T-cell expertise against aggressive lymphomas
October 07, 2022
More News
